SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly.

Hematology Reports
Matti Aapro

Abstract

A taskforce of the International Society of Geriatric Oncology (SIOG) has recently submitted recommendations on the use of anthracyclines in elderly patients. Despite the aging of the population and the high proportion of elderly individuals in the population of patients with non-Hodgkin's lymphoma, the development of specialist expertise in the treatment of elderly patients with cancer is relatively recent. Treatment of the elderly is complex because they are a highly heterogeneous population, with large variations in health status, comorbidities and life expectancy. In addition, these patients are generally more susceptible than young patients to the cardiotoxic effects of anthracyclines. Strategies for assessing elderly patients with cancer, reducing the risk of congestive heart failure, and assessing the cardiotoxic effects of treatments are discussed. In addition, a summary of the SIOG recommendations is presented.

References

Apr 28, 1990·Lancet·I S FentimanM S Aapro
Sep 24, 1998·The New England Journal of Medicine·P K Singal, N Iliskovic
Dec 30, 1999·The New England Journal of Medicine·L F HutchinsK S Albain
Apr 13, 2000·The New England Journal of Medicine·G M FelkerE K Kasper
Mar 15, 2002·Onkologie·C BokemeyerUNKNOWN DGHO/DGG study group "Geriatrische Onkologie" (Geriatric Oncology)
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Erik K FrommeTomasz M Beer
Aug 9, 2005·Critical Reviews in Oncology/hematology·Martine ExtermannUNKNOWN Task Force on CGA of the International Society of Geriatric Oncology
Oct 21, 2006·The Cochrane Database of Systematic Reviews·E C van DalenL C M Kremer
Oct 28, 2006·European Journal of Heart Failure·Mark BelhamColin Pritchard
May 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martine Extermann, Arti Hurria
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary C PinderSharon H Giordano
Jan 15, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Fotiní DodosUta C Hoppe
Jan 30, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S Ewer, Daniel J Lenihan
Apr 22, 2008·The Cochrane Database of Systematic Reviews·E C van DalenL C M Kremer
Aug 30, 2008·Critical Reviews in Oncology/hematology·Jean-Pierre DrozLodovico Balducci
Jan 8, 2010·Family Practice·Rosa MonteserinJaume Padrós
Oct 20, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AaproU Wedding
Jan 27, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A G PallisUNKNOWN European Organisation for Research and Treatment of Cancer Elderly Task Force

❮ Previous
Next ❯

Citations

Mar 12, 2015·Journal of Geriatric Oncology·Dipti GuptaRichard M Steingart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.